期刊文献+

重组人促红细胞生成素的不良反应 被引量:6

下载PDF
导出
作者 吕晶
出处 《中国药房》 CAS CSCD 2004年第10期624-625,共2页 China Pharmacy
  • 相关文献

参考文献20

  • 1谢红浪.重组人促红细胞生成素:老药新用途[J].肾脏病与透析肾移植杂志,2003,12(1):78-80. 被引量:1
  • 2[2]Eschbach JW. The anemia of chronic renal failure pathophysiology and the effects of recombinal erythropoietin[J]. Kidney Int, 1989,35:134.
  • 3[3]Delanty N, Vaughan C,Frucht S, et al .Erythropoietin associated hypertensive posterior leukoencephalopathy [J]. Neurology, 1997,49: 686.
  • 4[4]Caravaca F, Fernandez A,Barquilla JF,et al .Hypertensive crises following platelet transfusions in a patient on erythropoietin therapy [J] . Nephrol Dial Transplant , 1997,12(4) :815.
  • 5[5]Jaar B,Denis A, Viron B, et al .Effects of long- term treatment with recombinant human erythropoietin on physiologic inhibitors of coagulation[J] .Am J Nephrol,1997,17(5) :399.
  • 6[6]Iseki K,Nishime K,Uehara H,et al .Increased risk of cardiovascular disease with erythropoietin in chronic dialysis patients[J]. Nephron, 1996,72(1): 30.
  • 7[7]Pasquale F, Finelli, Matthew D, et al .Cerebral venous thrombosis associated with epoetin alfa therapy[J] .Arch Neurol, 2000, 57: 260.
  • 8[8]Wun T,Law L,Harvey D,et al .Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent- chemotherapy,radiation, and erythropoietin [J]. Cancer, 2003,98(7):1 514.
  • 9[9]Nissenson AR,Nimer SD,Wolcott DL.Recombinant human erythropoietin and renal anemia: molecular biology, clinical efficacy, and nerves system effects[J] .Ann Intern Med, 1991,114: 402.
  • 10瞿德佩.重组促红细胞生成素治疗尿毒症性贫血[J].中华肾脏病杂志,1993,9:43-45.

二级参考文献20

  • 1樊小兵,王庆文.促红细胞生成素引起高血压的可能机理[J].肾脏病与透析肾移植杂志,1995,4(6):548-550. 被引量:1
  • 2Sadamoto Y, Igase K, Sakanaka M et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun, 1998,253: 26
  • 3Sakanaka M, Wen TC, Matsuda S et al. In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc Natl Acad Sci USA,1998,92:4 640
  • 4Bemaudin M, Marti HH, Roussel S et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J Cereb Blood Flow Metab, 1999, 19:643
  • 5Junk Ak, Mammis A, Savitz S et al. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci ,2002,99:10 659
  • 6Buemi M, Grasso G, Corica F et al. In vivo evidence that erythropoietin prevents subarachnoid hemorrhage. Eur J Pharmacol,2000, 392:31
  • 7Alafaci C, Salpietro F, Grasso G et al. Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur J Pharmacol,2000, 406:21 915
  • 8Banerjee D, Rodriguez M, Nag M et al. Exposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activity.Kidney Int,2000, 57: 1 895
  • 9Buemi M, Allegra A, Aloisi C et al. Hemodynamic effects of recombinant human erythropoietin. Nephron, 1999, 81:1
  • 10Ammarguelat F, Gogusev J, Dmeke TB. Direct effect of erythropoietin on rat vascular smooth-muscle cells via a putative erythropoietin. Nephrol Dial Transplant, 1996,11:687

共引文献5

同被引文献62

引证文献6

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部